Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Nutritional Supplement
Aspire Biopharma Holdings
Healthy
1 trial -
Oligo Fucoidan
Biotech Pharmaceutical Co.,
NSCLC Stage IV
1 trial -
Olive oil
Universe Pharmaceuticals INC
Severe Obesity
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
PROGRAM
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Obesity
1 trial -
Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"
Atrium Therapeutics
Cancer
1 trial -
Platelet-rich plasma
COLLEGIUM PHARMACEUTICAL, INC
ACL Injury
1 trial -
Power Line Program
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Metabolic Health
1 trial -
Redefine
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Obesity & Overweight
1 trial -
Ropivacaine
Zealand Pharma A/S
Pain, Postoperative
1 trial -
S-ketamine
Nanjing Zenshine Pharmaceuticals
Opioid Use, Unspecified
1 trial -
Sapropterin
BioMarin Pharmaceutical Australia Pty Ltd
Hyperphenylalaninemia
1 trial -
Semaglutide
GT Biopharma
Obesity (Disorder)
1 trial -
Standard OGTT
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Standart medical treatment
Tarsus Pharmaceuticals
High Intensity Interval Training
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial -
Symbiotic Formula with DHA and antioxidants
Quantum Biopharma
Cystic Fibrosis
1 trial -
Thermal stress and performance without a pre-cooling protocol
Petros Pharmaceuticals
Risk of Heat Stress
1 trial -
Triferdine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Pregnancy Related
1 trial -
Ultrasound Elastography
Jazz Pharmaceuticals Ireland Limited
Bone Marrow Transplant Complications
1 trial -
Umooze
Biotech Pharmaceutical Co.,
Benign Prostatic Hyperplasia
1 trial -
Use of Mitomycin-C in trabeculectomy
AEON Biopharma
Open-angle Glaucoma
1 trial -
Uteratonic administration
Tarsus Pharmaceuticals
Placenta Abruptio
1 trial -
Volcolon sugar free
Teva Pharma GmbH
Constipation
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources